4 Dec 2017 12:37
Ideagen PLC
("Ideagen," "the Company" or the "Group'')
Exercise of Options and Total Voting Rights
Ideagen PLC (AIM: IDEA), a leading supplier of Information Management Software to highly regulated industries, announces that it has allotted 135,000 new ordinary shares of 1 penny each in the capital of the Company ("Ordinary Shares") following the exercise of share options by employees.
Application has been made to the London Stock Exchange for the 135,000 new Ordinary Shares to be admitted to trading on AIM ("Admission") and it is expected that Admission will become effective and trading will commence at 8.00 a.m. on 8 December 2017.
After Admission, the total number of Ordinary Shares in issue will be 200,210,018 and the total number of voting rights will therefore be 200,210,018. This figure may be used by shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.
Enquiries:
Ideagen plc | 01629 699100 |
David Hornsby, Chief Executive |
|
Graeme Spenceley, Finance Director |
|
|
|
finnCap Limited | 020 7220 0500 |
Stuart Andrews/Henrik Persson/James Thompson (Nomad) |
|
Stephen Norcross (Corporate Broking) |
|
|
|
|
|
About Ideagen plc
Ideagen is a UK company quoted on the London Stock Exchange AIM market (Ticker: IDEA.L).
Ideagen is a supplier of Information Management software with operations in the UK, the United States and the Middle East. The Company specialises in GRC (Governance, Risk and Compliance) and Content and Clinical solutions with a primary focus on organisations operating within highly regulated industries. With an excellent portfolio of software products, Ideagen is able to provide complete information lifecycle solutions that enable organisations to reduce risk, meet their regulatory and compliance standards, helping them to reduce costs and improve efficiency.
The Group has a customer base of over 3,000 organisations using the Ideagen suite of products, including many blue chip names such as BAE Systems, Emirates, Shell and the European Central Bank as well as 150 hospitals in the UK and US.
For further information please visit www.ideagen.com